We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.26 | -0.35% | 73.00 | 73.613 | 72.64 | 72.88 | 8,786,506 | 01:00:00 |
From Apr 2019 to Apr 2024
By Dave Sebastian
Boston Scientific Corp. said its profit rose for the first quarter as sales increased, including a 10% growth in its cardiovascular sales.
The Marlborough, Mass.-based medical-products company Wednesday posted net income of $341 million, compared with $11 million in the prior year. Earnings were 23 cents a share, compared with a penny a share in the year-ago period.
Adjusted earnings were 37 cents a share. Analysts polled by FactSet were looking for 31 cents a share. The company had guided earnings of 5 cents a share to 11 cents a share, and 28 cents a share to 34 cents a share on an adjusted basis.
Net sales rose 8.2% to $2.75 billion, ahead of its guidance of a flat to 6% growth. Analysts were looking for $2.62 billion.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
April 28, 2021 06:58 ET (10:58 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
